Results 71 to 80 of about 1,038 (149)

Dispensação de Oseltamivir no Município de Passo Fundo - RS

open access: yesRevista de Epidemiologia e Controle de Infecção, 2012
The knowledge of theuser profile of the antiviral oseltamivir (Tamiflu) can resultin benefits to develop prevention actions and strategiesand more effective treatment against influenza and itscomplications.
Gilberto Santetti, Anderson Flores
doaj  

Diseño y evaluación biológica de péptidos inmunológicamente activos contra la Influenza A Humana H1N1

open access: yes, 2015
La influenza es una enfermedad ampliamente distribuida a nivel mundial y es producida por el virus de la influenza, la cual genera más del 15% de las gripes a nivel mundial. En México desde el 2009 se reportaron después del brote más de 72,462 casos y 1,185 muertes, según un documento del INDRE (Abril 2010). Esta situación alertó a la población mundial
openaire   +1 more source

Detection and Genomic Characterization of an Avian Influenza Virus Subtype H5N1 (Clade 2.3.4.4b) Strain Isolated from a Pelican in Peru. [PDF]

open access: yesMicrobiol Resour Announc, 2023
Fernández-Díaz M   +6 more
europepmc   +1 more source

Influenza virus A H5N1 and H1N1: features and zoonotic potential Virus de Influenza A H5N1 y H1N1: características y potencial zoonótico Os virus da Influenza A H5N1 e H1N1: características e potencial zoonótico

open access: yesRevista Colombiana de Ciencias Pecuarias, 2011
Influenza A viruses which belong to the Orthomyxoviridae family, are enveloped, pleomorphic, and contain genomes of 8 single-stranded negative-sense segments of RNA. Influenza viruses have three key structural proteins: hemagglutinin (HA), neuraminidase (
Diana M Echeverry, Juan D Rodas
doaj  

[Acute Flacid Paralysis and Encephalitis: A Deadly Combination. Report of the Latest Case of Human Rabies in Colombia: A Reminder of a Preventable Enemy]. [PDF]

open access: yesRev Neurol
García Jimenez FA   +5 more
europepmc   +1 more source

[Environmental medicine and AI, migration, and emerging and reemerging diseases in Mexico]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Rivera-Silva G   +2 more
europepmc   +1 more source

Scientific publication speed and retractions of COVID-19 pandemic original articles. [PDF]

open access: yesRev Panam Salud Publica, 2022
Schonhaut L   +5 more
europepmc   +1 more source

Nudges to Clinicians and Patients for Influenza Vaccines During Visits: The BE IMMUNE Randomized Clinical Trial. [PDF]

open access: yesJAMA Intern Med
Mehta SJ   +13 more
europepmc   +1 more source

Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study. [PDF]

open access: yesBMJ Open
Adimadhyam S   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy